167 related articles for article (PubMed ID: 38254070)
1. Sequential gene expression analysis of myelodysplastic syndrome transformation identifies HOXB3 and HOXB7 as the novel targets for mesenchymal cells in disease.
Yin C; Li Y; Zhang C; Zang S; Wang Z; Yan X; Ma T; Li X; Li W
BMC Cancer; 2024 Jan; 24(1):111. PubMed ID: 38254070
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
3. [Senescent Mesenchymal Stem Cells Contribute to Progression of Myelodysplastic Syndromes-Review].
Pang YB; Li WW; Luo JM; Ji J; DU X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):942-946. PubMed ID: 29950248
[TBL] [Abstract][Full Text] [Related]
4. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
[TBL] [Abstract][Full Text] [Related]
5. Aberrant DNA methylation impacts HOX genes expression in bone marrow mesenchymal stromal cells of myelodysplastic syndromes and de novo acute myeloid leukemia.
Roux B; Picou F; Debeissat C; Koubi M; Gallay N; Hirsch P; Ravalet N; Béné MC; Maigre M; Hunault M; Mosser J; Etcheverry A; Gyan E; Delhommeau F; Domenech J; Herault O
Cancer Gene Ther; 2022 Aug; 29(8-9):1263-1275. PubMed ID: 35194200
[TBL] [Abstract][Full Text] [Related]
6. In vitro study of biological characteristics of mesenchymal stem cells in patients with low-risk myelodysplastic syndrome.
Zhang YZ; Zhao DD; Han XP; Jin HJ; Da WM; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):813-8. PubMed ID: 18718067
[TBL] [Abstract][Full Text] [Related]
7. MDS cells impair osteolineage differentiation of MSCs via extracellular vesicles to suppress normal hematopoiesis.
Hayashi Y; Kawabata KC; Tanaka Y; Uehara Y; Mabuchi Y; Murakami K; Nishiyama A; Kiryu S; Yoshioka Y; Ota Y; Sugiyama T; Mikami K; Tamura M; Fukushima T; Asada S; Takeda R; Kunisaki Y; Fukuyama T; Yokoyama K; Uchida T; Hagihara M; Ohno N; Usuki K; Tojo A; Katayama Y; Goyama S; Arai F; Tamura T; Nagasawa T; Ochiya T; Inoue D; Kitamura T
Cell Rep; 2022 May; 39(6):110805. PubMed ID: 35545056
[TBL] [Abstract][Full Text] [Related]
8. [Research Advances on the Senescence Mechanism of Bone Marrow Mesenchymal Stem Cells Derived from Patients with Myelodysplastic Syndrome--Review].
Tian MJ; Pang YB; Fan LX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):1002-1006. PubMed ID: 34105508
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of AURKA and AURKB genes in bone marrow stromal mesenchymal cells of myelodysplastic syndrome: correlation with G-banding analysis and FISH.
Oliveira FM; Lucena-Araujo AR; Favarin Mdo C; Palma PV; Rego EM; Falcão RP; Covas DT; Fontes AM
Exp Hematol; 2013 Feb; 41(2):198-208. PubMed ID: 23092930
[TBL] [Abstract][Full Text] [Related]
10. Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow.
Flores-Figueroa E; Varma S; Montgomery K; Greenberg PL; Gratzinger D
Lab Invest; 2012 Sep; 92(9):1330-41. PubMed ID: 22710983
[TBL] [Abstract][Full Text] [Related]
11. Functional characteristics of mesenchymal stem cells derived from bone marrow of patients with myelodysplastic syndromes.
Zhao ZG; Xu W; Yu HP; Fang BL; Wu SH; Li F; Li WM; Li QB; Chen ZC; Zou P
Cancer Lett; 2012 Apr; 317(2):136-43. PubMed ID: 22240014
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.
Huang HH; Chen FY; Chou WC; Hou HA; Ko BS; Lin CT; Tang JL; Li CC; Yao M; Tsay W; Hsu SC; Wu SJ; Chen CY; Huang SY; Tseng MH; Tien HF; Chen RH
BMC Cancer; 2019 Jun; 19(1):617. PubMed ID: 31234830
[TBL] [Abstract][Full Text] [Related]
13. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell-cell adhesion.
Roversi FM; Lopes MR; Machado-Neto JA; Longhini AL; Duarte Ada S; Baratti MO; Palodetto B; Corrocher FA; Pericole FV; Campos Pde M; Favaro P; Traina F; Saad ST
Stem Cells Dev; 2014 May; 23(10):1109-20. PubMed ID: 24410667
[TBL] [Abstract][Full Text] [Related]
14. [Study on phenotypic and cytogenetic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes].
Song LX; Guo J; He Q; Yang LP; Gu SC; Zhang Z; Zhang X; Wu LY; Li X; Chang CK
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):127-32. PubMed ID: 23611219
[TBL] [Abstract][Full Text] [Related]
15. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow MSCs in MDS: contribution towards dysfunctional hematopoiesis and potential targets for disease response to hypomethylating therapy.
Poon Z; Dighe N; Venkatesan SS; Cheung AMS; Fan X; Bari S; Hota M; Ghosh S; Hwang WYK
Leukemia; 2019 Jun; 33(6):1487-1500. PubMed ID: 30575819
[TBL] [Abstract][Full Text] [Related]
17. Significant improvement of bone marrow-derived MSC expansion from MDS patients by defined xeno-free medium.
Altrock E; Sens-Albert C; Hofmann F; Riabov V; Schmitt N; Xu Q; Jann JC; Rapp F; Steiner L; Streuer A; Nowak V; Obländer J; Weimer N; Palme I; Göl M; Darwich A; Wuchter P; Metzgeroth G; Jawhar M; Hofmann WK; Nowak D
Stem Cell Res Ther; 2023 Jun; 14(1):156. PubMed ID: 37287056
[TBL] [Abstract][Full Text] [Related]
18. The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes.
Wang Z; Tang X; Xu W; Cao Z; Sun L; Li W; Li Q; Zou P; Zhao Z
PLoS One; 2013; 8(3):e57470. PubMed ID: 23469196
[TBL] [Abstract][Full Text] [Related]
19. The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome.
Zheng L; Zhang L; Guo Y; Xu X; Liu Z; Yan Z; Fu R
Front Immunol; 2022; 13():1078421. PubMed ID: 36569863
[TBL] [Abstract][Full Text] [Related]
20. High expression of HOXB3 predicts poor prognosis and correlates with tumor immunity in lung adenocarcinoma.
Yan M; Yin X; Zhang L; Cui Y; Ma X
Mol Biol Rep; 2022 Apr; 49(4):2607-2618. PubMed ID: 35028857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
